“Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli

Abstract In 2015, the American company Turing Pharmaceuticals increased the price of the drug Daraprim by 5,000 percent overnight. Politicians and healthcare representatives accused Turing’s CEO, Martin Shkreli, of having harmed both vulnerable patient groups and the healthcare system. The present a...

Full description

Saved in:
Bibliographic Details
Main Author: Gustav Grut
Format: Article
Language:Danish
Published: De Nordiske Kriminalistforeninger 2019-12-01
Series:Nordisk Tidsskrift for Kriminalvidenskab
Online Access:https://tidsskrift.dk/NTfK/article/view/124798
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555050216816640
author Gustav Grut
author_facet Gustav Grut
author_sort Gustav Grut
collection DOAJ
description Abstract In 2015, the American company Turing Pharmaceuticals increased the price of the drug Daraprim by 5,000 percent overnight. Politicians and healthcare representatives accused Turing’s CEO, Martin Shkreli, of having harmed both vulnerable patient groups and the healthcare system. The present article aims to attain an understanding of how Shkreli justified increasing the price and restricting the distribution of the drug Daraprim. Statements made by Shkreli in four video interviews were analyzed on the basis of Sykes and Matza’s (1957) theoretical framework of neutralization techniques. All techniques of neutralization were identified. Shkreli shifted the blame to other actors, denied the existence of victims and of harm to the nation’s healthcare system, characterized his accusers as corrupt, and portrayed profit maximization as a more important goal than public health. Abstract År 2015 höjde det amerikanska företaget Turing Pharmaceuticals priset på läkemedlet Daraprim med 5000% över en natt. Politiker och representanter inom sjukvården beskyllde Turings VD, Martin Shkreli, för att ha skadat både sårbara patientgrupper och sjukvårdssystemet. Den aktuella artikeln syftar till att nå en förståelse av hur Shkreli rättfärdigade prishöjningen och den begränsade distributionen av Daraprim. Uttalanden från Shkreli i fyra intervjuer analyserades enligt Sykes och Matzas (1957) teoretiska ramverk neutralisationstekniker. Samtliga tekniker identifierades. Shkreli skuldbelade andra aktörer, förnekade existensen av offer samt skada på det amerikanska sjukvårdssystemet, skildrade fördömarna som korrupta och framställde vinstmaximering som ett viktigare mål än folkhälsa.
format Article
id doaj-art-eb33056b8cb74ad6a0c8b4ef2fb4755e
institution Kabale University
issn 2446-3051
language Danish
publishDate 2019-12-01
publisher De Nordiske Kriminalistforeninger
record_format Article
series Nordisk Tidsskrift for Kriminalvidenskab
spelling doaj-art-eb33056b8cb74ad6a0c8b4ef2fb4755e2025-01-08T07:29:37ZdanDe Nordiske KriminalistforeningerNordisk Tidsskrift for Kriminalvidenskab2446-30512019-12-01106334936410.7146/ntfk.v106i3.124798118022“Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin ShkreliGustav GrutAbstract In 2015, the American company Turing Pharmaceuticals increased the price of the drug Daraprim by 5,000 percent overnight. Politicians and healthcare representatives accused Turing’s CEO, Martin Shkreli, of having harmed both vulnerable patient groups and the healthcare system. The present article aims to attain an understanding of how Shkreli justified increasing the price and restricting the distribution of the drug Daraprim. Statements made by Shkreli in four video interviews were analyzed on the basis of Sykes and Matza’s (1957) theoretical framework of neutralization techniques. All techniques of neutralization were identified. Shkreli shifted the blame to other actors, denied the existence of victims and of harm to the nation’s healthcare system, characterized his accusers as corrupt, and portrayed profit maximization as a more important goal than public health. Abstract År 2015 höjde det amerikanska företaget Turing Pharmaceuticals priset på läkemedlet Daraprim med 5000% över en natt. Politiker och representanter inom sjukvården beskyllde Turings VD, Martin Shkreli, för att ha skadat både sårbara patientgrupper och sjukvårdssystemet. Den aktuella artikeln syftar till att nå en förståelse av hur Shkreli rättfärdigade prishöjningen och den begränsade distributionen av Daraprim. Uttalanden från Shkreli i fyra intervjuer analyserades enligt Sykes och Matzas (1957) teoretiska ramverk neutralisationstekniker. Samtliga tekniker identifierades. Shkreli skuldbelade andra aktörer, förnekade existensen av offer samt skada på det amerikanska sjukvårdssystemet, skildrade fördömarna som korrupta och framställde vinstmaximering som ett viktigare mål än folkhälsa.https://tidsskrift.dk/NTfK/article/view/124798
spellingShingle Gustav Grut
“Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli
Nordisk Tidsskrift for Kriminalvidenskab
title “Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli
title_full “Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli
title_fullStr “Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli
title_full_unstemmed “Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli
title_short “Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli
title_sort ethics are generally not in play here the neutralization techniques of the bad boy of pharma martin shkreli
url https://tidsskrift.dk/NTfK/article/view/124798
work_keys_str_mv AT gustavgrut ethicsaregenerallynotinplayheretheneutralizationtechniquesofthebadboyofpharmamartinshkreli